https://orcid.org/0000-0002-6809-6964
Figures & data
Figure 1 Study design.
Abbreviations: COPD, chronic obstructive pulmonary disease; FEV1, forced expiratory volume in 1 second; BDP/FF, beclometasone and formoterol fixed-dose combination inhaler; FP/SAL, fluticasone propionate and salmeterol fixed-dosed combination inhaler; BUD/FF, budesonide and formoterol fixed-dose combination inhaler.
Table 1 Patient Flow and Inclusion and Exclusion Criteria
Table 2 Matched Baseline Patient Characteristics
Figure 2 Odds ratios for COPD exacerbation between BDP/FF and FP/SAL or BUD/FF.
Notes:aAdjusted for baseline ICS/LABA combination-inhaler prescriptions, baseline SABA prescriptions, baseline SAMA/SABA prescriptions, and active anxiety/depression. bAdjusted for theophylline prescription, ischemic heart disease diagnosis, and LTRA prescriptions. cAdjusted for SABA daily dose, ICS prescriptions, hypertension, and diabetes diagnosis.
Abbreviations: POP, population size; OR odds ratio; LCL, lower confidence interval; UCL, upper confidence interval.
